Birdwatch Note Rating
2023-04-08 19:17:28 UTC - HELPFUL
Rated by Participant: A588A04CED95D885AB71074931EDCF1BF7507296DCE4ABDE016773F46080DBBF
Participant Details
Original Note:
A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study
All Note Details